Ketamine therapy represents a different approach to treating certain mental health conditions, particularly depression, anxiety, and post-traumatic stress disorder (PTSD). Unlike traditional antidepressants that work by adjusting serotonin levels over weeks or months, ketamine works through a different mechanism in the brain. It affects glutamate, a neurotransmitter that plays a role in how brain cells communicate and form new connections.
Learn About Paying Your FGUA Bill Online →
Originally developed as an anesthetic in the 1960s, ketamine has been used in hospitals and surgical settings for decades. Medical professionals noticed that patients receiving ketamine sometimes showed rapid improvements in mood, even at doses lower than those used for anesthesia. This observation led researchers to investigate whether controlled ketamine treatment could help people with treatment-resistant depression—a condition where standard antidepressants haven't worked.
The therapy typically involves receiving ketamine in a medical setting under professional supervision. Doses are carefully measured and monitored. Some facilities offer intravenous (IV) infusions, where ketamine enters the bloodstream through a vein. Others provide intramuscular injections or nasal spray formulations. The specific approach depends on the provider, the condition being treated, and individual patient factors. A single treatment session might last 40 minutes to several hours, depending on the method used.
One reason ketamine therapy has gained attention is the speed at which some people report changes. Some individuals describe feeling differently within hours or days, whereas traditional antidepressants often take two to four weeks to show effects. This rapid action has made ketamine particularly interesting for people in crisis or those who haven't responded to other treatments.
Practical takeaway: Understanding that ketamine therapy operates through a different biological pathway than traditional medications helps explain why it may work for some people when other treatments haven't. Knowing the basic mechanism—how it affects glutamate and brain cell connections—provides useful context for conversations with healthcare providers.
Ketamine therapy isn't delivered in just one way. Several formats exist, each with different characteristics regarding how the drug enters the body, how long treatment takes, and what the experience involves. Knowing the differences helps you understand what to expect if you're considering this option.
Free Guide to Pay by Plate Illinois Billing →
Intravenous (IV) infusions remain the most common format in clinical settings. During an IV infusion, ketamine flows directly into a vein through a thin tube. A healthcare provider monitors heart rate, blood pressure, and oxygen levels throughout the session. IV infusions typically last 40 minutes to an hour for each treatment, though the entire appointment may take longer when you include check-in time and monitoring afterward. Many clinics recommend a series of infusions—often six to eight sessions over two to three weeks—though this varies based on individual response and the provider's protocol.
Intramuscular (IM) injections deliver ketamine through a shot into muscle tissue. These sessions tend to be shorter than IV infusions, sometimes lasting 15 to 20 minutes for the injection itself. The effects may be felt more quickly with IM administration. Some providers use this method when IV placement isn't practical or when a patient prefers injections over infusions.
Nasal spray ketamine (esketamine, marketed as Spravato) represents a newer option. This formulation was approved by the FDA in 2019 for treatment-resistant depression. Nasal spray administration happens in a medical office, where you self-administer the spray while a provider observes. Sessions are typically shorter than infusions. The frequency of treatment varies—initial treatment might involve twice-weekly sessions, tapering to weekly or less frequent doses as time goes on.
Oral ketamine tablets or lozenges exist but are less common in clinical settings. Some research clinics use oral formulations for specific studies. Home-based oral ketamine therapy remains largely experimental and is not standard clinical practice outside of research environments.
Each format comes with different considerations regarding convenience, cost, monitoring intensity, and how quickly effects appear. The choice often depends on the specific clinic's offerings, your medical history, insurance coverage possibilities, and what your healthcare provider recommends.
Practical takeaway: Different ketamine delivery methods offer tradeoffs between treatment duration, frequency of visits, and speed of effect. Knowing these differences lets you ask informed questions when speaking with providers about which format might fit your life and health situation.
Ketamine therapy providers operate in several different settings, each with varying levels of oversight, pricing structures, and clinical focus. Understanding where these providers work helps you evaluate options and understand what to expect.
Free Guide to Mold Removal Methods for Walls →
Academic medical centers and university hospitals often have ketamine therapy programs, usually attached to psychiatry or anesthesiology departments. These settings typically have extensive research components and may offer treatment at lower costs than private clinics. However, availability may be limited, and there might be waitlists. The advantage is that academic centers tend to have rigorous protocols and multiple specialists on staff.
Private ketamine clinics have emerged in many cities across the United States. These are standalone or multi-location facilities dedicated primarily to ketamine therapy. They typically operate independently from hospitals. Private clinics often have more flexible scheduling than academic centers and may accept various insurance types, though many operate on a cash-pay basis. Costs at private clinics vary widely—anywhere from $500 to $2,000 per infusion depending on location, clinic reputation, and additional services provided.
Psychiatry practices and mental health clinics increasingly offer ketamine therapy as one treatment option among many. Some practices partner with specific clinics or administer treatments on-site if they have the proper licensing and facilities. This format can be convenient if you already work with a psychiatrist, as coordination between your regular mental health care and ketamine treatment may be smoother.
Telehealth ketamine therapy has emerged in some markets. These services typically don't conduct the actual infusion or injection remotely—that still happens at a local clinic or partner facility—but may handle initial consultations, follow-up care, and monitoring through video calls. This option can reduce the burden of traveling to far-away specialists.
When searching for providers, resources like the American Society of Ketamine Professionals, state medical boards, and local psychiatric associations maintain lists of practitioners. Your current doctor may provide referrals. Reviews on medical sites like Healthgrades or Zocdoc offer patient perspectives, though individual experiences vary. When contacting potential providers, ask about their credentials, how long they've offered ketamine therapy, what their success rates look like, and how they handle follow-up care.
Practical takeaway: Different provider settings—academic, private clinics, psychiatric practices, and telehealth—each offer different advantages regarding cost, convenience, and integrated care. Start by identifying which types exist in your area, then compare their specific protocols and what they emphasize about their approach to treatment.
Ketamine therapy addresses several mental health and pain conditions, though the strength of research evidence varies. Understanding which conditions have the strongest evidence base helps set realistic expectations about what the treatment might accomplish.
How to Delete Your Fitbit Account Guide →
Treatment-resistant depression (TRD) has the strongest evidence base for ketamine therapy. TRD specifically refers to depression that hasn't improved after trying at least two different antidepressants at adequate doses for sufficient time. Studies show that 50 to 70 percent of people with TRD experience significant symptom improvement with ketamine therapy. The FDA approved esketamine nasal spray specifically for TRD in adults in 2019, which represents official recognition that ketamine treatment has clinical value for this particular condition.
Major depressive disorder without the treatment-resistant designation is increasingly studied and treated with ketamine, though the evidence is still developing. Some people with standard depression respond well to ketamine, particularly when speed of response matters—for instance, if someone is at high risk for suicide.
Suicidal ideation and acute suicidality have emerged as areas where ketamine's rapid action holds promise. Some research suggests that ketamine can reduce suicidal thoughts within hours to days. This potential application has significant implications for crisis situations where standard interventions take longer. However, this use remains primarily in research and specialized clinical settings, not yet standard practice everywhere.
PTSD shows promising early research results with ketamine therapy, often combined with psychotherapy. The theory is that ketamine's effects on brain plasticity
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.